Metropolis Healthcare Limited has informed the Exchange regarding 'Business Responsibility and Sustainability Report for the financial year 2024-25'.
METROPOLIS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Metropolis Healthcare has filed its Business Responsibility and Sustainability Report for FY 2024-25 as part of its Annual Report, in line with SEBI's listing regulations. The company operates a diagnostic testing business with 215 locations across India (210) and Africa (5), serving 28 states and 7 union territories domestically plus 17 international markets. Key disclosures include a workforce of 5,180 employees and workers (37% female), turnover of ₹1,21,654 lakhs, and net worth of ₹1,24,445 lakhs. The company has set sustainability targets including carbon neutrality by 2043, zero waste by 2030, and 50:50 gender balance by 2028. Notable FY25 achievements include a 30% reduction in energy emissions, NPS score of 87, and ISO 27001/27701 certifications for data security and privacy.
This is a routine regulatory compliance filing that forms part of the company's Annual Report and does not directly affect stock price or shareholder value. However, it provides investors visibility into Metropolis's ESG performance, operational scale, workforce composition, and long-term sustainability commitments.